We are studying how hematopoietic cell fate is specified, maintained, and eventually modified or reversed. Inspired from the fields of stem cell biology, immunology, and cancer we use an interdisciplinary approach to mechanistically understand hematopoietic and immune cell identities and translate our findings into novel gene and cell therapies.
Ontogenic Shifts in Cellular Fate Are Linked to Proteotype Changes in Lineage-biased Hematopoietic Progenitor Cells
Maria Jassinskaja, Kristýna Pimková, Nejc Arh, Emil Johansson, Mina Davoudi, Carlos-Filipe Pereira, Ewa Sitnicka, Jenny Hansson
March 23, 2021 / Volume 34, Issue 23
Harnessing the Potential of Cell Fate Reprogramming for Cancer Immunotherapy
March 17, 2021
MSc. Thesis - University of Vienna
We are a diverse group – molecular biologists, MDs, PharmDs, tumor immunologists, stem cell biologists and computational scientists – at all career stages. We architect strategies to dissect and manipulate immune cell identity.
Looking for an opportunity? Join our international team!
Filipe Pereira Is The New Editor-in-Chief of Cellular Reprogramming
Following on the legacy of Professor Sir Ian Wilmut, Filipe Pereira becomes the new Editor-in-Chief of the Cellular Reprogramming Journal.
Filipe Pereira Awarded a Swedish Research Council Consolidator Grant
The Swedish Research Council (Vetenskapsrådet) has published the results for this year’s applications for consolidator grants, in which Filipe Pereira was selected for, in the scientific area of Medicine and health.
Luís Oliveira Awarded a PhD Studentship From The Foundation for Science and Technology
Pereira Lab researcher Luís Oliveira was awarded a fully funded 4 year scholarship by the Portuguese Foundation for Science and Technology (FCT) to develop his PhD-leading research.